The formation of human gonads is an exquisitely timed developmental event, occurring during embryogenesis with critical milestones set between four to six weeks post-fertilization. During this early embryonic window, the bipotential gonadal ridges differentiate into either testes or ovaries based on tightly regulated genetic and molecular cues. Studying this sex determination process has historically been fraught with complexity, hindered by its timing, ethical challenges surrounding human embryonic research, and notable species-specific differences that limit animal model extrapolation. Consequently, a complete understanding and modeling of atypical gonadal development have remained elusive, obstructing advances in diagnostics and therapeutics for DSDs.

DSDs encompass a heterogeneous group of rare conditions characterized by discordance between chromosomal sex and gonadal or anatomical sexual differentiation. Affecting approximately one in 4,500 live births, these conditions range from severe presentations detected prenatally or shortly after birth, to milder variations that may manifest at puberty or remain undiagnosed into adulthood. Despite advances in genetic sequencing over the past decade and the identification of numerous causative genes, roughly half of DSD cases with atypical gonad development still lack definitive genetic diagnoses, underscoring unmet clinical needs and the necessity for more predictive disease models.

Addressing these challenges, the research team utilized human induced pluripotent stem cells (hiPSCs), which possess the remarkable ability to differentiate into multiple cell types, to recreate key cellular constituents of the ovary. Specifically, hiPSCs were guided to become granulosa-like cells, a crucial somatic cell population responsible for nurturing maturing oocytes and supporting follicle formation. Concurrently, primordial germ cell-like cells (PGCLCs), precursors to future gametes, were generated. By co-culturing and combining these two cell populations without introducing exogenous transcription factors—which can artificially alter intrinsic genetic programs—the researchers successfully engineered complex ovarian organoids that faithfully recapitulate vital structural and functional hallmarks of human ovarian follicles.

This methodological breakthrough diverges significantly from prior models that often relied on forced expression of external transcription factors, which risk disrupting authentic developmental gene regulatory networks and limit relevance to disease modeling. According to senior author Dr. Anu Bashamboo, this endogenous differentiation strategy preserves the innate genetic programs within the cells, enhancing the fidelity and applicability of the derived populations to investigate natural ovarian development and pathology. Importantly, the functioning ovaroids exhibit critical cell-cell interactions and three-dimensional morphogenesis reflective of in vivo ovarian tissue architecture.

Complementing this advancement, collaborative work previously conducted at the Institut Pasteur and the Francis Crick Institute successfully generated hiPSC-derived somatic cells of the testis, namely Sertoli cells, which play a vital role in testicular development and are frequently implicated in DSDs. By cultivating cells carrying male sex chromosomes (XY) with genetic mutations associated with atypical testis formation, the team observed impaired formation of three-dimensional tubular structures reminiscent of seminiferous tubules, resulting in dysgenetic gonadal features analogous to human DSD phenotypes. Together, these parallel models of ovarian and testicular development establish a versatile platform for comparative analyses of gonadal biology.

The implications of these human-specific, stem cell-derived models extend far beyond basic science. They address critical limitations imposed by interspecies variation, where fundamental differences in gene regulation impede the translation of findings from animal models to humans. By enabling controlled, reproducible studies of human gonadal development, gene function, and disease mechanisms, this platform represents a transformative toolset for dissecting the molecular underpinnings of DSDs and related reproductive disorders.

Dr. Bashamboo highlights the broader significance of this research, emphasizing its capacity to bridge the divide between laboratory investigation and clinical application. The human ovaroid and testicular cell systems not only hold promise for advancing genetic diagnosis through improved modeling of previously cryptic conditions but also serve as scalable platforms for drug screening, toxicological assessment, and personalized medicine. Their utility could accelerate the development of targeted therapeutics tailored to individuals with infertility, gonadal tumors, or atypical sexual development.

Moreover, the potential for these organoids to facilitate environmental and pharmacological screenings represents a timely innovation, given increasing concerns about endocrine-disrupting chemicals and their effects on human reproductive health. By providing a physiologically relevant system, researchers can assess the impact of diverse compounds on human gonadal cells and structures in vitro, informing safer medical and environmental policies.

Looking towards the future, these stem cell-derived human gonadal models offer exciting possibilities for therapeutic interventions. With continued refinement, they may underpin regenerative strategies or novel approaches to restore or modulate gonadal function in patients affected by congenital anomalies or acquired diseases. The integration of such models within precision medicine frameworks could revolutionize fertility preservation, diagnosis, and treatment paradigms.

In summary, the development of human ovaroids from hiPSCs marks a pivotal advancement in reproductive biology research, pushing the boundaries of what can be studied and manipulated in human tissue models. It was presented at the first Joint Congress of ESPE and ESE, symbolizing a collaborative milestone in endocrine and reproductive science. With their robust and faithful recapitulation of ovarian follicular structures without exogenous genetic manipulation, these ovaroids provide a potent new avenue for unraveling developmental mysteries, improving diagnostic accuracy, and pioneering therapeutic innovations for complex gonadal conditions.

—

Subject of Research: Development of human ovary organoids (ovarioids) from induced pluripotent stem cells to model gonadal development and differences in sex development (DSDs)

Article Title: Not provided

News Publication Date: Not provided

Web References: Not provided

References: Not provided

Image Credits: European Society of Endocrinology

Keywords: Ovaries, Ovarian follicles, Reproductive system, Gonads, Testicles, Endocrine system, Endocrinology, Hormones, Cell cultures, Research methods, Laboratory procedures, Germ cells, Primordial germ cells, Differentiated cells, Pluripotent stem cells, Infertility, Ovarian tumors, Pediatrics, Diseases and disorders, Stem cell development, Sertoli cells, Stem cells

Throughout the scientific community, the quest to unveil the mysteries of fertilization and early embryonic development has been met with significant hurdles. Traditional methodologies have often posed ethical dilemmas and practical limitations, as actual embryos are typically cultivated within the uterus of a gestating organism, and this natural environment makes direct observational research exceedingly challenging. As a result, a field has emerged that seeks alternative avenues to explore these biological phenomena, prompting UCSC researchers to innovate radically through synthetic biology.

Led by a team of enthusiastic scientists that includes postdoctoral scholar Gerrald Lodewijk and graduate student Sayaka Kozuki, the UCSC researchers focused on employing mouse stem cells as a foundation to recreate this complex biological system. Utilizing an advanced approach called epigenome editing, which differs from conventional CRISPR methodologies by modifying gene expression without cutting the DNA itself, they adeptly directed these cells to form embryoid structures. This technique not only streamlines cellular organization but also spares them from irreversible genomic alterations.

By targeting specific genomic regions critical to early embryonic development, the researchers were able to control the expression of relevant genes, thereby guiding the formation of vital cell types. This enabling technology revealed an impressive phenomenon: approximately 80% of the stem cells self-organized into structures that reflect the foundational architecture of a developing embryo within mere days. Such a striking outcome highlights the inherent capabilities of stem cells, which, under the right conditions, exhibit impressive autonomy in establishing organized patterns.

The process proposed by this research initiates a radical shift in our current understanding of embryogenesis. Shariati, a leading expert in the realm of stem cell engineering, emphasizes the significance and ambition of their endeavor. “Our aim is to replicate and manipulate natural processes, such as embryonic formation, outside the natural context. We want to unlock the cellular choreography of self-organization that takes place within an embryo and to decipher the underlying factors that cause malformations under pathological conditions,” he states.

The crux of their methodology hinges not only on the CRISPR tools utilized but also on the self-organization capability of the stem cells themselves. As Lodewijk enthusiastically relays, “We’ve harnessed the blank canvas that is the stem cell, allowing it to orchestrate a developmental journey that mirrors biological embryonic progression. Our CRISPR-based interventions simply guide the cells, unleashing their intrinsic potential to self-assemble.” This innovative interplay between technology and biological systems illustrates the enormous promise of programmable biological practices.

Stunningly, the embryoids formed did not merely mimic structural characteristics; they also exhibited collective behavior reminiscent of natural embryonic cells co-developing. The research team noted instances of cooperative cell migration, similar to flocking birds, as the cells enacted complex patterns utilized in the maturation process. Instead of manipulating their genomes or relying on extrinsic substances, the researchers activated latent genes, allowing the embryoid structures to emerge organically, with minimal intervention.

By creating these programmable embryoid models, scientists have opened the door to a new era of biological analysis. These models not only provide a more accurate representation of the early developmental stages of life but also afford researchers the opportunity to conduct targeted studies on gene activation and its associated consequences. Such insights are essential for understanding the mechanisms behind developmental disorders, genetic mutations, and the myriad of factors that can hinder proper embryonic development.

Moreover, researchers view the study as a pioneering leap towards explorations of early development across various species. The implications are profound, extending the framework of embryological study beyond merely mammalian systems, potentially encompassing any number of species while minimizing ethical concerns commonly associated with embryo research. As this avenue of exploration broadens, new horizons emerge in fertility research and interventions, potentially paving the path for breakthroughs in reproductive health that could assist humans with specific fertility issues.

Ultimately, this research represents a vanguard of hope, suggesting the possibility of refining our understanding of why certain reproductive processes fail. Given the fact that human embryos often confront significant challenges during early development, this programmable model’s potential to illuminate underlying pathologies influencing reproductive success is invaluable. A thorough understanding of these complexities could lay the groundwork for future advancements in reproductive science that enhance fertility outcomes.

The UC Santa Cruz team’s published findings in the prestigious journal Cell Stem Cell facilitate a seismic shift in the landscape of embryology and stem cell research. As they continue to refine their techniques and delve deeper into the genetics governing early development, the research holds tremendous promise for medical and ethical advancements alike, heralding a future where understanding the building blocks of life may one day become our greatest asset in tackling developmental anomalies and reproductive challenges.

Through these innovative approaches, researchers are setting new precedents in synthetic biology and regenerative medicine, fostering an environment where scientists can creatively engage with the complex nature of life, armed with powerful tools to probe, manipulate, and ultimately reimagine the essence of developmental biology.

Their results, awe-inspiring in both their scientific merit and the ethical avenues they open, position the University of California, Santa Cruz, at the forefront of an emerging paradigm shift within the biological sciences, laying the groundwork for a future where the deep complexities of life can be explored in new ways, unlocking the mysteries that have long eluded biologists for centuries.

Subject of Research: Programmable cellular models of embryos known as embryoids
Article Title: Self-organization of embryonic stem cells into reproducible pre-gastrulation embryo models via CRISPRa programming
News Publication Date: 20-Mar-2025
Web References: http://dx.doi.org/10.1016/j.stem.2025.02.015
References: Cell Stem Cell
Image Credits: Ali Shariati/UC Santa Cruz

Keywords

embryonic development, CRISPR technology, programmable models, stem cells, embryo formation, cellular models, genetic engineering, reproductive health, developmental disorders